According to study, “Asia-Pacific Medical Robot Market (2018-2023)”
some of the major companies that are currently working in the Asia-Pacific
medical robot market are Omnicell Inc., Ekso Bionics Holdings Inc., Titan
Medical, Rewalk Robotics, Baxter International, Abbot Diagnostics, Carefusion,
Elekta, Kirby Lester LLC, Apex Automation and Robotics, Intuitive Surgical,
Aurora Biomed, Roche Holdings AG, Hansen Medical Inc., Biotek Instruments,
Stanmore Implants Worldwide, IRobot Corp., KUKA, Midea-Yaskawa, Shenzhen
Sanggu, Honda Robotics, Agilent Technologies, Toyota, Beijing Tinavi, Stryker
Corporation, Cyberdyne, Aesynt, Daihen Corp, Mazor Robotics Ltd., Renishaw
Plc., Nikkei, Beijing Bohuiweikang Technology, Arxium, Accuray Inc., Chongqing
Jinshan Science and Technology, Varian, Ossur, Hocoma AG.
Medical robots are that robots,
which are used for remotely operating computers for accessing information. They
restore or adjust patient’s body function or a body part. The medical robots provide
modern analytical facilities and highest possible comfort for the patients. It
also adds the competences and facilities for performing smaller and new
specific as well as correct invasions. Medical robots are categorized into
surgical robots, biorobots, telepresence robots, rehabilitation robots,
disinfection robots, companion robots and pharmacy automation robots etc. Main
features are less blood loss, smaller scars, faster recovery, less pain,
accuracy and shorter hospital stay etc. Some important medical robots are the
Da Vinci Surgical Robot and ViRob Miniature medical robot.
On the basis of component, the
medical robot market is segmented into user interface, visualization system,
locomotion systems, software platform, power sources and safety systems etc. On
the basis of product, the market is segmented into rehabilitation robot,
instruments & accessories, surgical robot, non-invasive radio surgery robot
and others. Rehabilitation robots are further sub-segmented into prosthetic
robots, exoskeleton robots, therapeutic robot and assistive robots etc.
Surgical robots are made up of cardiology surgery robotic systems, orthopedic
surgical robotic systems, laparoscopic surgical robotic systems, neurological
surgery robotic systems and steerable robotics. In addition, hospital and
pharmacy automation robots are consist by telemedicine Robots, IV robots and
pharmacy automation robots. On the basis of application, the market is
segmented into orthopedic, laparoscopy, neurology and cardiology etc.
The Asia-Pacific medical robot is
mainly driven by huge population followed by rising awareness and growing
hospital investments in medical robots, and increasing prevalence of diseases, development
of new technologies advancements, increasing in funding for medical robots
research and government regulation and policies etc. Growth of the market can
primarily be attributed to robot-assisted training in rehabilitation therapy,
increase in funding for medical robot research, and the issuance of IPOs by medical robot companies.
Apart from advantages, some of the
challenges include lack of logistic facilities, lack of transportation,
increasing cost of treatment etc.
In India, healthcare industry is
in very tough situation owing to goods and services tax (GST). GST is
responsible for high cost of necessary healthcare facilities such as various
health treatment and hospital room rent etc. The inadequate distribution of
healthcare services in small pockets is foremost threat of market.
Japan, China and India are three
key countries that have helped in the development of medical robotics market in
the Asia Pacific region. These countries are starting many startups to deliver
higher care systems for surgeries and cures. It is expected that Asia-Pacific
medical robot market will be reached at 3.4 billion, at a CAGR of 18.7%, by
2023.
To know more, click on the link below:
Related Reports :
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
